Press release
Klebsiella pneumoniae Infections – Pipeline Therapeutics by Companies Nosopharm ,Novartis ,Peptilogics, Pfizer ,Phico ,Shionogi ,Soligenix
Klebsiella pneumoniae Infections
Latest Pharmaceutical and Healthcare disease pipeline guide Klebsiella pneumoniae Infections - Pipeline Review, H2 2018, provides an overview of the Klebsiella pneumoniae Infections (Infectious Disease) pipeline landscape.
Request a sample report @ https://www.htfmarketreport.com/sample-report/1429047-klebsiella-pneumoniae-infections-pipeline-review-5
Klebsiella pneumoniae is a Gram-negative bacteria. A Klebsiella pneumoniae infection is caused when the organism is able to enter the lungs. A Klebsiella pneumoniae infection is very common in patients with underlying diseases like diabetes, chronic lung diseases and chronic alcoholics. It is mostly a nosocomial infection that occurs in hospitalized patients with weakened immune system. Symptoms include necrosis, inflammation, hemorrhage, chills, dizziness, high fever, head ache and chest pain. Treatment includes antibiotics and hygiene lifestyle.
Report Highlights
Pharmaceutical and Healthcare latest pipeline guide Klebsiella pneumoniae Infections - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Klebsiella pneumoniae Infections (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Klebsiella pneumoniae Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Klebsiella pneumoniae Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase I, Preclinical and Discovery stages are 1, 3, 29 and 11 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 6 and 2 molecules, respectively.
Klebsiella pneumoniae Infections (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Klebsiella pneumoniae Infections (Infectious Disease).
- The pipeline guide reviews pipeline therapeutics for Klebsiella pneumoniae Infections (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Klebsiella pneumoniae Infections (Infectious Disease) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Klebsiella pneumoniae Infections (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Klebsiella pneumoniae Infections (Infectious Disease)
Buy this report @ https://www.htfmarketreport.com/buy-now?format=1&report=1429047
Reasons to buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Klebsiella pneumoniae Infections (Infectious Disease).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Klebsiella pneumoniae Infections (Infectious Disease) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Companies Mentioned in the Report
ABAC Therapeutics SA
Acies Bio doo
AmpliPhi Biosciences Corp
Appili Therapeutics Inc
BB200 LLC
C3J Therapeutics Inc
ContraFect Corp
Daiichi Sankyo Co Ltd
Debiopharm International SA
Evaxion Biotech ApS
F. Hoffmann-La Roche Ltd
Kyorin Pharmaceutical Co Ltd
LegoChem Biosciences Inc
Meiji Seika Pharma Co Ltd
Melinta Therapeutics Inc
Microbiotix Inc
Nosopharm SAS
Novartis AG
Peptilogics Inc
Pfizer Inc
Phico Therapeutics Ltd
Shionogi & Co Ltd
Soligenix Inc
Spero Therapeutics Inc
Summit Therapeutics Plc
Syntiron LLC
Tetraphase Pharmaceuticals Inc
Vaxdyn SL
Venus Medicine Research Center
Get customization & check for discount @ https://www.htfmarketreport.com/request-discount/1429047-klebsiella-pneumoniae-infections-pipeline-review-5
About Author:
HTF Market Report is a wholly owned brand of HTF market Intelligence Consulting Private Limited. HTF Market Report global research and market intelligence consulting organization is uniquely positioned to not only identify growth opportunities but to also empower and inspire you to create visionary growth strategies for futures, enabled by our extraordinary depth and breadth of thought leadership, research, tools, events and experience that assist you for making goals into a reality. Our understanding of the interplay between industry convergence, Mega Trends, technologies and market trends provides our clients with new business models and expansion opportunities. We are focused on identifying the “Accurate Forecast” in every industry we cover so our clients can reap the benefits of being early market entrants and can accomplish their “Goals & Objectives”.
Contact US :
Craig Francis (PR & Marketing Manager)
HTF Market Intelligence Consulting Private Limited
Unit No. 429, Parsonage Road Edison, NJ
New Jersey USA – 08837
+1 (206) 317 1218
sales@htfmarketreport.com
Connect with us at
https://www.linkedin.com/company/13388569/
https://twitter.com/htfmarketreport
https://www.facebook.com/htfmarketintelligence/
https://plus.google.com/u/0/+Htfmarketreportinsights
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Klebsiella pneumoniae Infections – Pipeline Therapeutics by Companies Nosopharm ,Novartis ,Peptilogics, Pfizer ,Phico ,Shionogi ,Soligenix here
News-ID: 1328059 • Views: …
More Releases from HTF Market Intelligence Consulting Private Limited
Homeschooling Market May See a Big Move | Major Giants Time4Learning, K12 Inc
HTF MI just released the Global Homeschooling Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Key Players in This Report Include:
Time4Learning, K12 Inc (Stride), Abeka, Sonlight, Khan…
Virtual Anatomy Table Market May See a Big Move | Major Giants Anatomage, Sectra
HTF MI just released the Global Virtual Anatomy Table Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Key Players in This Report Include:
Anatomage, Sectra, Synaptive Medical, 3D…
Technical and Vocational Education Market May See a Big Move | Major Giants Simp …
HTF MI just released the Global Technical and Vocational Education Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Key Players in This Report Include:
Pearson, NIIT, TVTC, Laureate…
Distance Learning Solutions Market Is Booming Worldwide | Major Giants Coursera, …
HTF MI just released the Global Distance Learning Solutions Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Key Players in This Report Include:
Coursera, Udemy, edX, Blackboard, Canvas…
More Releases for Klebsiella
Klebsiella pneumoniae Infections Market is expected to reach USD 7.21 billion by …
The global Klebsiella pneumoniae Infections Market was valued at USD 3.85 billion in 2024 and is expected to reach USD 7.21 billion by 2034, growing at a CAGR of 6.5% during the forecast period (2025-2034). Rising antimicrobial resistance (AMR), increasing hospitalization rates, expanding ICU admissions, and the growing prevalence of community- and hospital-acquired infections are key factors driving market growth.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71746
Klebsiella pneumoniae…
Klebsiella Pneumoniae Infections Market is projected to reach USD 5.0 billion by …
Klebsiella pneumoniae is a Gram-negative bacterium responsible for a wide range of healthcare- and community-acquired infections, including pneumonia, bloodstream infections, urinary tract infections (UTIs), and liver abscesses. It is a major concern in intensive care units (ICUs) and among immunocompromised patients.
The growing global burden of antimicrobial resistance (AMR) has made Klebsiella pneumoniae one of the most dangerous pathogens, particularly strains resistant to carbapenems, cephalosporins, and aminoglycosides. The World Health Organization…
Klebsiella Infections Therapeutics- Pipeline Analysis 2018, Clinical Trials & Re …
Klebsiella infections include different types of infections like bloodstream infections; pneumonia; wound or surgical site infections; and meningitis, caused by the Klebsiella bacteria. The symptoms associated with these infections are high fevers, chills, cough, and shortness of breath.
Download the sample report @ https://www.pharmaproff.com/request-sample/1065
Hospitalized patients undergoing treatment for other conditions may be susceptible to these infections. In healthcare settings, patients who require long courses of antibiotics, or are treated with…
Klebsiella Pneumoniae Infections Market Symptoms, Consulting Services, Epidemiol …
Klebsiella Pneumoniae Infections Market Epidemiology outlays comprehensive Insight of the disease, historical & forecasted epidemiology as well as the market trends of Klebsiella Pneumoniae Infections Industry. The Report provides a detailed picture of the current treatment practices, emerging drugs, a market share of the individual therapies, current and forecasted market size of Klebsiella Pneumoniae Infections.
The Klebsiella Pneumoniae Infections Market Report also covers current treatment practice/algorithm, market drivers, market barriers and…
Klebsiella pneumoniae Infections Market : Potential and Niche Segments, Geograph …
ReportBazzar has released its latest research-based report entitled ‘Klebsiella pneumoniae Infections’ market.
This report provides a holistic approach to the market growth with a detailed and precise analysis of the overall competitive scenario of the Klebsiella pneumoniae Infections market. The report also provides a detailed analysis of key trends and latest technologies, playing a prominent role in the Klebsiella pneumoniae Infections market growth. It takes into account aspects such as drivers,…
Klebsiella pneumoniae Infections (Infectious Disease) Pipeline Forecast Report, …
Market Research Hub's latest Pharmaceutical and Healthcare disease pipeline guide Klebsiella pneumoniae Infections - Pipeline Review, H1 2017, provides an overview of the Klebsiella pneumoniae Infections (Infectious Disease) pipeline landscape. Klebsiella pneumoniae is a Gram-negative bacteria. A Klebsiella pneumoniae infection is caused when the organism is able to enter the lungs. A Klebsiella pneumoniae infection is very common in patients with underlying diseases like diabetes, chronic lung diseases and chronic…
